Freedom of Information

Q1. How many patients were treated in the last 3 months by the Dermatology department (for any medical condition) with the following biologic drugs:

• Adalimumab - Humira
• Adalimumab Biosimilar
• Apremilast
• Bimekizumab
• Brodalumab
• Certolizumab
• Deucravacitinib
• Dimethyl fumarate
• Etanercept - Enbrel
• Etanercept Biosimilar
• Guselkumab
• Infliximab - Remicade
• Infliximab Biosimilar
• Ixekizumab
• Risankizumab
• Secukinumab
• Tildrakizumab
• Ustekinumab

Q2. How many patients were treated in the last 3 months by the Dermatology department for Psoriasis only in the last three months with the following:

• Ciclosporin
• Methotrexate - any form and strength
• Methotrexate injections 15mg and above